Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Liu, Hua ^a   Shah, Sudhir V ^b   Baliga, Radhakrishna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cytochrome P 450 inhibitors; Glomerular epithelial cells; Puromycin aminonucleoside; Reactive oxygen metabolites

Indexed keywords

CIMETIDINE; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; HEMOPROTEIN; HYDROXYL RADICAL; IRON; PIPERONYL BUTOXIDE; PUROMYCIN AMINONUCLEOSIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYST; CONTROLLED STUDY; CYTOTOXICITY; GLOMERULUS EPITHELIUM; KIDNEY MICROSOME; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0035000022     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.1.f88     Document Type: Article

References (35)

1. Adams NH, Levi PE, and Hodgson E. Regulation of cytochrome P-450 isozymes by methylenedioxyphenyl compounds. Chem Biol Interact 86: 255-274, 1993.
2. Baird MB, Sfeir GT, and Slade-Pacini CD. Lack of inhibition of mouse catalase activity by cimetidine: an argument against a relevant general effect of cimetidine upon home metabolic pathways. Biochem Pharmacol 36: 4366-4369, 1987.
3. Baliga R, Baliga M, and Shah SV. Effect of selenium deficient diet in experimental glomerular disease. Am J Physiol Renal Fluid Electrolyte Physiol 263: F56-F61, 1992.
4. Baliga R, Ueda N, and Shah SV. Increase in bleomycin-detectable iron in ischemia/reperfusion injury to rat kidneys. Biochem J 291: 901-905, 1993.
5. Baliga R, Ueda N, and Shah SV. Oxidant mechanisms in glomerular disease. In: Current Nephrology. Chicago, IL: Year Book, 1997, vol. 20, p. 135-151.
6. Baliga R, Zhang Z, Baliga M, and Shah SV. Evidence for cytochrome 450 as a source of catalytic iron in the myoglobinuric acute renal failure. Kidney Int 49: 362-369, 1996.
7. Baliga R, Zhang Z, Baliga M, Ueda N, and Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53: 394-401, 1998.
8. Baliga R, Zhang Z, Baliga M, Ueda N, and Shah SV. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 54: 1562-1569, 1998.
9. 1 cells. Kidney Int 50: 1118-1124, 1996.
10. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, and Hoidal JR. Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 86: 1434-1441, 1990.
11. Couser WG. Glomerular disorders. In: Cecil Textbook of Medicine, (19th ed.). Philadelphia, PA: Saunders, 1992, p. 551-568.
12. Dahl AR and Hodgson E. The interaction of aliphatic analogs of methylenedioxyphenyl compounds with cytochromes P-450 and P-420. Chem Biol Interact 27: 163-175, 1979.
13. Glassock RJ, Adler SG, Ward HJ, and Cohen AH. Primary glomerular disease. In: The Kidney, (4th ed.). Philadelphia, PA: Saunders, 1991, p. 1182-1279.
14. Gutteridge JM, Cao W, and Chevion M. Bleomycin-detectable iron in brain tissue. Free Radic Res Commun 11: 317-320, 1991.
15. Gutteridge JM, Rowley DA, and Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem J 199: 263-265, 1981.
16. Gutteridge JM, Rowley DA, and Halliwell B. Superoxide-dependent formation by hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem J 206: 605-609, 1982.
17. Halliwell B and Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85, 1990.
18. Kappus H. Metabolic reactions: role of cytochrome P450 in the formation of reactive oxygen species. Handb Exp Pharm 105: 145-154, 1993.
19. Karuzina II and Archakov AI. Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions. Free Radic Biol Med 17: 557-567, 1994.
20. Kasinath BS. Effect of insulin on high-glucose medium-induced changes in rat glomerular epithelial cell metabolism of glycoconjugates. Arch Biochem Biophys 318: 286-294, 1995.
21. Kawaguchi M, Yamada M, Wada H, and Okigaki T. Role of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 72: 329-340, 1992.
22. Kutty RK, Nagineni CN, Kutty G, Hooks JJ, Chader GJ, and Wiggert B. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 159: 371-378, 1994.
23. Lannigan R, Kark R, and Pollak VE. The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: a light and electronmicroscope study. J Pathol Bacteriol 83: 357-362, 1962.
24. Omura T and Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
25. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol Renal Fluid Electrolyte Physiol 255: F539-F544, 1988.
26. Paller MS and Jacob HS. Cytochrome P-450 mediates tissue damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91: 7002-7006, 1994.
27. Ponka P. Cellular iron metabolism. Kidney Int 69: S2-S11, 1999.
28. Ponticelli C and Passerini P. Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 46: 595-604, 1994.
29. Rendic S, Kajfez F, and Ruf HH. Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P450. Drug Metab Dispos 11: 137-142, 1983.
30. Ricardo SD, Bertram JF, and Ryan GB. Reactive oxygen species in puromycin amnonucleoside nephrosis: in vitro studies. Kidney Int 45: 1057-1069, 1994.
31. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989.
32. Trakshel GM, Kutty RK, and Maines MD. Purification and characterization of the major constitutive form of testicular heme oxygenase. J Biol Chem 261: 11131-11137, 1986.
33. Ueda N, Baliga R, and Shah SV. Role of "catalytic" iron in animal model of minimal change nephrotic syndrome. Kidney Int 49: 370-373, 1996.
34. Ueda N, Guidet B, and Shah SV. Gentamicin-induced mobilization of iron from renal cortical mitochondria. Am J Physiol Renal Fluid Electrolyte Physiol 265: F435-F439, 1993.
35. 2, and terminal mitochondrial electron transport. Kidney Int 51: 728-738, 1997.